Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Sybleu (OTC : SYBE) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
SYBLEU Inc. is engaged in the acquisition, licensing and development of medical and veterinary applications. The Company is focused on developing therapies for human and animal health, medical devices, and clinical diagnostics. The Company is also developing drugs for treating cancer in companion animals and examining the role of artificial intelligence and machine learning in clinical diagnostics. It is also involved in the development of disposable medical devices. It has completed Phase I and or Phase II clinical trials after which the Company would either attempt to sell or license those developed applications or, alternatively, advance the application further to Phase III clinical trials.
Quote
| Last: | $0.055 |
|---|---|
| Change Percent: | 12.75% |
| Open: | $0.04799 |
| Close: | $0.055 |
| High: | $0.055 |
| Low: | $0.041 |
| Volume: | 8,513 |
| Last Trade Date Time: | 07/15/2024 03:00:00 am |
Stock Data
| Market Cap: | $583,550 |
|---|---|
| Float: | 2,953,824 |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Country: | US |
| City: | BRONX |
**MWN-AI FAQ is based on asking OpenAI questions about Sybleu (OTC: SYBE).
